European shares steady; Middle East tensions in focus
European shares steady; Middle East tensions in focus For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window
June 9 (Reuters) - European shares were steady at open as the developments in the Middle East stayed in focus, with oil prices easing after Iran and Israel halted attacks on U.S. President Donald Trump's appeal.
The pan-European STOXX 600 index .STOXX edged 0.1% higher to 622.68 points by 0708 GMT.
Crude oil prices erased nearly all of the previous session's gains after Iran and Israel halted attacks on each other, though investors remained cautious as diplomatic talks so far have failed to deliver a lasting peace and the Strait of Hormuz, a vital artery for global oil supplies, remains shut.
Inflation concerns have had markets price in a 25-basis-point interest rate hike by the European Central Bank at the meeting on Thursday, but the focus will be on the monetary policy path ahead.
Healthcare stocks .SXDP declined the most among sectors, falling 0.8%. GSK GSK.L slipped 2% after the British drugmaker agreed to acquire U.S.-listed cancer drug developer Nuvalent NUVL.O for $10.6 billion.
Tech stocks rose 0.9% after global AI-related stocks, which had faced a selloff after a strong run, showed signs of steadying.
UBS UBSG.S rose 1.5%. A Reuters report said that Swiss lawmakers are considering a new pitch to soften capital requirements on the lender that could shave billions of dollars off the burden the bank is facing.
(Reporting by Utkarsh Hathi and Johann M Cherian in Bengaluru; Editing by Janane Venkatraman)
Recent news on AstraZeneca
See all newsUK Stocks-Factors to watch on July 10 (updated)
UK Stocks-Factors to watch on July 10
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight (updated)
US appeals court upholds win for AstraZeneca in Pfizer cancer drug patent fight
UK's FTSE 100 ticks lower as AstraZeneca drag offsets banks, mining gains